CHTN_Lung_SCC_Misc1 - Lung Squamous Cell and Miscellaneous Carcinoma

TMA Map

Code Key

Annotation Key

Label (Guide Sheet column)	Data Description
QC Diagnosis	Pathologic Diagnosis at baseline (per CHTN histologic QC assessment)
Baseline Stage	Prognostic Stage Group at baseline*
Baseline TNM	Pathologic TNM Stage at baseline*
QC Grade	Tumor Grade at baseline (per CHTN histologic QC assessment)*
Margin Status	Margin Status for baseline tumor resection
Tumor Location	baseline resected tumor location (L/R = left/right; UL/ML/LL = upper lobe/middle lobe/lower lobe)
Largest tumor on CT/PET scan	largest dimension of largest tumor nodule on CT/PET scan prior to baseline surgery (cm)
PET scan results	metabolic status of tumor on PET scan prior to baseline surgery if performed
Chest Wall/Mediastinal Invasion	presence of chest wall of mediastinal invasion at baseline
GGO appearance	presence of pulmonary ground glass opacity at baseline
PD-L1 status	PD-L1/CD274 immunohistochemistry result (per CHTN histologic assessment)
Age	subject age at diagnosis (years)
Race	subject race
Sex	subject sex
Height	subject height at baseline (cm)
Weight	subject weight at baseline (kg)
Hx of Cancer	subject history of cancer at baseline (any type)
Family Hx of Lung Cancer	subject familiy history of lung cancer
Smoking Hx	subject smoking status at baseline
PkYrs	total pack years if smoker
Pre-op Chemo	neo-adjuvant chemotherapy received prior to baseline surgery
Pre-op Radiation	neo-adjuvant radiation therapy recevied prior to baseline surgery
Pre-Baseline Surgeries	surgical lung surgeries received pre-baseline surgery
Post-baseline Chemo	chemotherapy received post-baseline surgery
Post-baseline Radiation	radiation therapy received post-baseline surgery
Post-baseline Surgeries	additional lung surgical procedures received post-baseline surgery
End of Study Status	subject status at end of 5-year followup or last known
Survival Status	subject cause of death if deceased
Last Available Disease Status	subject disease status at time of last followup contact
Survival Time	elapsed time to death, last contact, or end of study followup (days)
Recurrence Post-baseline	documented recurrence post-baseline surgery (Yes/No)
Metastasis Post-baseline	documented metastasis post-baseline surgery (Yes/No)
Time to First Recurrence/Metastasis	elapsed time to first recurrence or metasatasis from baseline surgery (days)
	*American Joint Committee on Cancer Cancer Staging Manual, 7th Ed.

Back Return to top